<< home
Roger W. Orlando to responds to concerned Accutane Recall Clients
Wednesday, April 28, 2010
Thank you for contacting The Orlando Firm, P.C. in response to the FDA Accutane Recall website.
Please read this entire, short email.
We have received a very large volume of inquiries as this issue potentially effects our health in a significant way.
*****NOTE: ONLY A DOCTOR CAN ULTIMATELY DIAGNOSE ANY PROBLEMS ASSOCIATED WITH THE USE OF ACCUTANE AND FDA-ACCUTANE-RECALL.COM WILL NOT REPLACE A CONSULTATION WITH A PROFESSIONAL MEDICAL PROVIDER!*****
POTENTIAL INJURY CLAIMS:
Ultimately we seek to help individuals who have experienced Intestinal Problems, Ulcerative Colitis, Crohn’s Disease, Inflammatory Bowel Disease (IBD).
*****NOTE: IF YOU ARE UNSURE OR ARE SEEKING FURTHER MEDICAL TESTING - AS MANY OF YOU HAVE WRITTEN IS YOUR INTENT - THEN TAKE THIS LIST OF CONDITIONS WITH YOU FOR YOUR DOCTOR TO CONSIDER IN RELATION TO YOUR USE OF THE FOLLOWING:
- ROACCUTANE (HOFFMAN-LA ROCHE; SIMPLY ACCUTANE BEFORE JULY 2009)
- AMNESTEEM (MYLAN)
- CLARAVIS (BARR)
- CLARUS (PREMPHARM)
- DECUTAN (ACTAVIS)
- ISOTANE (PACIFIC PHARMACEUTICALS)
- IZOTEK (BLAUFARMA)
- ORATANE (GENEPHARM AUSTRALASIA)
- ISOTRET (LIVA HEALTHCARE LTD.) OR SOTRET (RANBAXY)
- TOPICAL ISOTRETINOIN ISOTREX OR ISOTREXIN (STIEFEL) PRODUCTS.
Please feel free to write me back directly. Roger@OrlandoFirm.com I usually answer my own emails unless the number becomes too great for me to handle alone. If so, we have an amazing and caring staff to assist you as well, always under my careful oversight and direction.
Thank you once again for your trust and confidence in contacting my law firm and me.
Roger
Current News
Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis
Accutane Recall
Quick Contact
Time is of the essence in these very sensitive cases. Simply use the form below and an Attorney will contact you shortly.
Free Case Evaluation
Find out quickly - with no cost or obligation - if you might be entitled to a large cash settlement. Simply complete the Case Evaluation Form.